This article is more than 5 years old. Information may no longer be current.

Quidel to distribute I-Med dry eye products in U.S.

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

I-Med Pharma Inc. announced an exclusive U.S. distribution agreement with Quidel Corp. covering I-Med’s Lid ‘n Lash line, I-Relief Hot & Cold Therapy Eye Mask with Thermabeads and the SMTube.

“This is the start to a very promising partnership with a company that shares our drive and commitment to improving the ocular health of patients globally,” I-Med President Daniel Hofmann said in the release. “We are confident that this alliance will lead to many further collaborations in the future.”

I-Med Pharma is a Canadian company specializing in dry eye diagnosis and management, and Quidel Corp. provides rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, including InflammaDry and AdenoPlus Eye Health.

“We are pleased to partner with I-Med in providing ocular patients and health care providers with test-and-treat solutions at the point of care," Rick Graham, senior director, business development for Quidel, said in the release. “We look forward to growing the eye health business in the future through further I-Med product introductions, as well as added diagnostic testing opportunities."